Park CK, Oh HJ, Kim YC, Kim YH, et al. Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Durvalumab after Chemoradiotherapy: PACIFIC-KR. J Thorac Oncol 2023 Apr 19:S1556-0864(23)00495.
PMID: 37085032